CD14 and Toll-like Receptors 2 and 4 Are Required for Fibrillar A{beta}-stimulated Microglial Activation
Overview
Affiliations
Microglia are the brain's tissue macrophages and are found in an activated state surrounding beta-amyloid plaques in the Alzheimer's disease brain. Microglia interact with fibrillar beta-amyloid (fAbeta) through an ensemble of surface receptors composed of the alpha(6)beta(1) integrin, CD36, CD47, and the class A scavenger receptor. These receptors act in concert to initiate intracellular signaling cascades and phenotypic activation of these cells. However, it is unclear how engagement of this receptor complex is linked to the induction of an activated microglial phenotype. We report that the response of microglial cells to fibrillar forms of Abeta requires the participation of Toll-like receptors (TLRs) and the coreceptor CD14. The response of microglia to fAbeta is reliant upon CD14, which act together with TLR4 and TLR2 to bind fAbeta and to activate intracellular signaling. We find that cells lacking these receptors could not initiate a Src-Vav-Rac signaling cascade leading to reactive oxygen species production and phagocytosis. The fAbeta-mediated activation of p38 MAPK also required CD14, TLR4, and TLR2. Inhibition of p38 abrogated fAbeta-induced reactive oxygen species production and attenuated the induction of phagocytosis. Microglia lacking CD14, TLR4, and TLR2 showed no induction of phosphorylated IkappaBalpha following fAbeta. These data indicate these innate immune receptors function as members of the microglial fAbeta receptor complex and identify the signaling mechanisms whereby they contribute to microglial activation.
Pathogenesis and therapeutic applications of microglia receptors in Alzheimer's disease.
Fu J, Wang R, He J, Liu X, Wang X, Yao J Front Immunol. 2025; 16:1508023.
PMID: 40028337 PMC: 11867950. DOI: 10.3389/fimmu.2025.1508023.
Campomayor N, Kim H, Kim M Biomol Ther (Seoul). 2025; 33(2):235-248.
PMID: 39962769 PMC: 11893490. DOI: 10.4062/biomolther.2024.224.
Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer's Disease.
Lee E, Chang Y Cells. 2025; 14(3).
PMID: 39936960 PMC: 11817173. DOI: 10.3390/cells14030168.
Kenzelmann A, Boch C, Schmidt R, Richter M, Schulz M Biomedicines. 2025; 12(12.
PMID: 39767701 PMC: 11673003. DOI: 10.3390/biomedicines12122794.
Shang Y, Wang Z, Yang F, Wang W, Tang Q, Guo X Mol Med. 2024; 30(1):222.
PMID: 39563263 PMC: 11577590. DOI: 10.1186/s10020-024-00994-6.